Pre-treatment inflammatory biomarkers predict early treatment response and favorable survival in patients with metastatic colorectal cancer who underwent first line cetuximab plus chemotherapy

  • Jinling Jiang, Tao Ma, Wenqi Xi, Chen Yang, Junwei Wu, Chenfei Zhou, Nan Wang, Zhenggang Zhu, Jun Zhang
  • Cancer Management and Research, September 2019, Taylor & Francis
  • DOI: 10.2147/cmar.s211089

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2147/cmar.s211089

The following have contributed to this page: Professor JUN ZHANG

join the fight against climate change

Our simple summaries of climate research help you take action

Read now

climate-change.info